ro's glp 1 insurance coverage checker 2025 GLP-1 Report Ro launches the GLP-1 Insurance

This review examines the effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on different heart failure phenotypes with preserved ejection fraction

As 2025 gets underway, we take a look at what lies ahead for the highly dynamic market for effective anti-obesity medications (AOMs)

A Breakthrough Award, New Evidence in Parkinson's and Heart Disease

Stock screener for investors and traders, financial visualizations.

Two recent studies suggest that treating obesity and metabolic dysfunction with GLP-1 drugs could help restore hormonal balance and reproductive function in both women and men.

Explore the best alternatives to tirzepatide for weight loss, from semaglutide to retatrutide, compounded options, and natural approaches with data.